offers university-level education taught by professors and lecturers from academia and industry.
sitem-insel Enabling Facilities
provides infrastructure to foster cooperation between industrial partners, basic science, and clinic.
The mission of sitem-insel is to create and foster an enhanced environment for translational medicine in Switzerland. The strategy is based on three pillars:
university education for professionals in medical devices and life sciences industry
sitem-insel Enabling Facilities
specialized R&D workshops, laboratories, and equipment for industry, and academia
sitem-insel Promoting Services
promotes innovation and optimizes administrative and regulatory effort from bench to bedsides
sitem-insel aims to establish and operate a national center of competence for translational medicine in Bern
Translational medicine deals with the transition from new findings and products from industrial development and basic research to clinical application. This process-oriented discipline professionalizes the interaction between industry, universities, clinicians, regulatory bodies and investors.
sitem-insel is an independent, non-profit public-private partnership with the legal form of a public limited company. Government funding of appr. CHF 50m has been approved for the start-up phase. Subsequently, sitem-insel will be financially independent.
MDR/IVDR 2020, Implant files and beyond - are you ready?
sitem-insel organizes together with its partners from University of Bern and from Universität Hamburg the first Open Strategy Paper Development Workshop on October 11, 2019. The keynote will be held by Richard Whittington from Saïd Business School, University of Oxford.
The MDR Support Panel presents and discusses various solutions for the implementation of the MDR concerning third party country requirements.
The University of Bern and the Diabetes Center Berne (DCB) are together creating four professorships in the field of diabetes technology research and development. This will boost the international profile of diabetes research in Bern and strengthen its role as a center of medicine in the long term.
The new lecture hall at sitem-insel was crowded when people from industry, public offices and academia got together at the sitem-insel School Symposium «Bringing Innovation to the Patient».
Am 9. April 2019 hat das nationale Kompetenzzentrum für Translationale Medizin ein Herzstück für seine wissenschaftliche Forschung und Arbeit erhalten. Der heute stärkste verfügbare Magnetresonanztomograph (MRI) Magnetom Terra (7 Tesla) mit klinischer Zulassung sowie das High End System Magnetom Prisma (3 Tesla) von Siemens Healthineers wurden am Dienstag, 9. April 2019 angeliefert. In einer spektakulären logistischen Aktion brachten Spezialisten die tonnenschweren Geräte über eine Bodenöffnung ins 2. UG ein. Von dort wurden die Geräte über eine 100 Meter lange Distanz an ihren Bestimmungsort transportiert.
Conventional pacemakers have batteries which are responsible for the power supply of the device. These batteries have a finite energy storage capacity, which is why pacemaker generator changes are frequent due to battery exhaustion. Pacemakers without batteries are therefore highly desirable. Reoperations and resulting complications can thus be avoided. The following article by among others sitem-insel employee Dr. Adrian Zurbuchen gives an insight into the research and development activities in the field of battery-free pacemakers.